Mercer International Inc. to Present at Upcoming CIBC Investor Conference

NEW YORK, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Mercer International Inc. (Nasdaq: MERC) today announced that Juan Carlos Bueno, President and Chief Executive Officer, and Richard Short, Chief Financial Officer & Secretary, will be presenting at the following upcoming conference:

27th Annual CIBC Western Institutional Investor Conference
Wednesday, January 17, 2024 - Friday, January 19, 2024
Fairmont Chateau Whistler, 4599 Chateau Boulevard, Whistler, British Columbia
Presentation at 8:35 a.m. PST on Thursday, January 18, 2023

A copy of the presentation will be posted in the “Investors - News Releases & Presentations” section on the Company’s website (https://mercerint.com/investors/news-releases-presentations/) in advance of the event.

About Us

Mercer International Inc. is a global forest products company with operations in Germany, the United States and Canada with consolidated annual production capacity of 2.3 million tonnes of pulp, 960 million board feet of lumber, 210,000 cubic meters of cross-laminated timber, 45,000 cubic meters of glulam, 17 million pallets and 230,000 metric tonnes of biofuels. For further information, please visit www.mercerint.com.

The preceding includes forward-looking statements, which involve known and unknown risks and uncertainties which may cause our actual results in future periods to differ materially from forecasted results. Among those factors which could cause actual results to differ materially are the following: the continuing effects of the recent economic and financial turmoil, the highly cyclical nature of our business, raw material costs, our level of indebtedness, competition, foreign exchange and interest rate fluctuations, our use of derivatives, expenditures for capital projects, environmental regulation and compliance, disruptions to our production, market conditions and other risk factors listed from time to time in our SEC reports.

You May Also Be Interested In

• Matinas BioPharma to merge with GH Power, sell drug unit to Azurity
• CoStar Group names Robin Rossmann as CFO, effective July 2026
• Mesoblast reaches 300-patient enrollment in back pain Phase 3 trial